Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Holman

Showing results (321-330 of 716) with videos related to

Pageof 72
Sort By:
The New England Journal of Medicine|November 18, 1976
Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseasesG C Sharp, W S Irvin, C M May, et al.
Biochemistry|December 14, 2005
Spectroscopic and biochemical characterization of heme binding to yeast Dap1p and mouse PGRMC1pKaushik Ghosh, Alisha M Thompson, Robert A Goldbeck, et al.
Journal of Clinical Epidemiology|March 17, 2004
Scaling the sickness impact profile using item response theory: an exploration of linearity, adaptive use, and patient driven item weightsR Lindeboom, R Holman, M G W Dijkgraaf, et al.
Inorganic Chemistry|July 29, 2008
Geometric structure determination of N694C lipoxygenase: a comparative near-edge X-ray absorption spectroscopy and extended X-ray absorption fine structure studyRitimukta Sarangi, Rosalie K Hocking, Michael L Neidig, et al.
Diabetes Care|December 31, 2008
Performance of the UK Prospective Diabetes Study Risk Engine and the Framingham Risk Equations in Estimating Cardiovascular Disease in the EPIC- Norfolk CohortRebecca K Simmons, Ruth L Coleman, Hermione C Price, et al.
Pharmacology & Therapeutics|October 23, 2018
Role of the 12-lipoxygenase pathway in diabetes pathogenesis and complicationsA D Dobrian, M A Morris, D A Taylor-Fishwick, et al.
European Journal of Heart Failure|October 9, 2024
Cardiovascular outcomes with exenatide in type 2 diabetes according to ejection fraction: The EXSCEL trialJoão Sérgio Neves, Ana Rita Leite, Robert J Mentz, et al.
Journal of the American College of Cardiology|December 13, 2006
Cardiac resynchronization therapy in patients with a narrow QRS complexGabe B Bleeker, Eduard R Holman, Paul Steendijk, et al.
Tissue Antigens|April 26, 2002
Sequence of two new HLA-Cw alleles: HLA-Cw*0313 and HLA-Cw*1208S T Cox, H Ogilvie, E M Bohan, et al.
Diabetes Research and Clinical Practice|July 24, 2020
Predicting post one-year durability of glucose-lowering monotherapies in patients with newly-diagnosed type 2 diabetes mellitus - A MASTERMIND precision medicine approach (UKPDS 87)Olorunsola F Agbaje, Ruth L Coleman, Andrew T Hattersley, et al.
Pageof 72

Showing results (321-330 of 716) with videos related to

Sort By:
Pageof 72
The New England Journal of Medicine|November 18, 1976
Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseasesG C Sharp, W S Irvin, C M May, et al.
Biochemistry|December 14, 2005
Spectroscopic and biochemical characterization of heme binding to yeast Dap1p and mouse PGRMC1pKaushik Ghosh, Alisha M Thompson, Robert A Goldbeck, et al.
Journal of Clinical Epidemiology|March 17, 2004
Scaling the sickness impact profile using item response theory: an exploration of linearity, adaptive use, and patient driven item weightsR Lindeboom, R Holman, M G W Dijkgraaf, et al.
Inorganic Chemistry|July 29, 2008
Geometric structure determination of N694C lipoxygenase: a comparative near-edge X-ray absorption spectroscopy and extended X-ray absorption fine structure studyRitimukta Sarangi, Rosalie K Hocking, Michael L Neidig, et al.
Diabetes Care|December 31, 2008
Performance of the UK Prospective Diabetes Study Risk Engine and the Framingham Risk Equations in Estimating Cardiovascular Disease in the EPIC- Norfolk CohortRebecca K Simmons, Ruth L Coleman, Hermione C Price, et al.
Pharmacology & Therapeutics|October 23, 2018
Role of the 12-lipoxygenase pathway in diabetes pathogenesis and complicationsA D Dobrian, M A Morris, D A Taylor-Fishwick, et al.
European Journal of Heart Failure|October 9, 2024
Cardiovascular outcomes with exenatide in type 2 diabetes according to ejection fraction: The EXSCEL trialJoão Sérgio Neves, Ana Rita Leite, Robert J Mentz, et al.
Journal of the American College of Cardiology|December 13, 2006
Cardiac resynchronization therapy in patients with a narrow QRS complexGabe B Bleeker, Eduard R Holman, Paul Steendijk, et al.
Tissue Antigens|April 26, 2002
Sequence of two new HLA-Cw alleles: HLA-Cw*0313 and HLA-Cw*1208S T Cox, H Ogilvie, E M Bohan, et al.
Diabetes Research and Clinical Practice|July 24, 2020
Predicting post one-year durability of glucose-lowering monotherapies in patients with newly-diagnosed type 2 diabetes mellitus - A MASTERMIND precision medicine approach (UKPDS 87)Olorunsola F Agbaje, Ruth L Coleman, Andrew T Hattersley, et al.
Pageof 72